Objectives: To determine whether Gulf War veterans with neuromuscular symptoms that included weakness and fatigue had either 1) objective correlates for muscle weakness or fatigue; or 2) any etiologic explanation for such symptoms; and if so, 3) whether such objective measures or etiologic mechanisms were specific to Gulf War service. Methods: Forty-nine ill Gulf War veterans with more than four neuromuscular symptoms (Gulf-ill) were compared with 26 Gulf-well veterans, 13 symptomatic Bosnian veterans (Bosnia-ill), and 22 symptomatic troops who were not deployed to the Gulf (Era-ill). Quantitative myometry was used to objectively measure weakness and fatigue. Subjects had an ischemic forearm exercise test, a subanaerobic bicycle exercise test, and a muscle biopsy. Results: Quantitative strength and fatigue measures did not correlate with self-perception of weakness or fatigue for any of our groups. No specific muscle biopsy abnormalities were found. There was no defect of adenylate deaminase or glycogenolysis found. Gulf-ill subjects did find the subanaerobic bicycle exercise more effortful and generated significantly higher plasma lactate concentrations compared with Gulf-well subjects. Conclusion: Because complaints of weakness and fatigue in unwell servicemen do not correlate with actual weakness or fatigue, explanations for these symptoms must lie outside of the neuromuscular system. Increased lactate production during subanaerobic bicycle exercise reflects mitochondrial inefficiency, but it is unclear whether this reflects mitochondrial damage sustained during Gulf War service or inactivity secondary to ill health.
There has been considerable concern expressed by the media, politicians, and ex-servicemen and exservicewomen regarding possible long-term effects of service in the 1991 Persian Gulf War. Neuromuscular symptoms, including weakness and fatigue, have figured prominently in Gulf War symptom surveys. [1] [2] [3] Despite this, there have been no reports of weakness found on neurologic examination of veterans and few reports of muscle biopsy results that may explain the basis for the symptoms of weakness or fatigue. One study on a self-reporting group of patients complaining of severe muscle fatigue, weakness, or myalgias lasting Ն6 months, sufficient to interfere with activities of daily living, assessed manual muscle strength of 36 muscle groups with Medical Research Council grading, as well as creatine kinase (CK) assays and open muscle biopsies. Muscle strength was normal. CK was increased in six subjects, five of whom were muscular black men who tend to have higher CK levels than the "normal." 4 There were three abnormal muscle biopsies: two with rare (Ͻ1%) tubular aggregates and one with occasional necrotic fibers. 5 A neurophysiologic study reported by us did not show any abnormalities specific to Gulf War illness. 6 Neurophysiologic studies may not detect upper motor neuron weakness. However, it may be that the weakness perceived by veterans is relative to a greater degree of strength expected as normal for trained military personnel and that a decline from this level, although noticed by the individual, still does not fall below that perceived as normal by the examining physician.
Fatigue is a subjective symptom with a complex phenomenology, and the symptoms of fatigue and weakness may overlap, even though the two are physiologically different. Thus, a fatigued subject may complain of weakness in the absence of actual weakness. Fatigue itself has a multitude of possible, sometimes overlapping, explanations, including those caused by neuromuscular pathology, that would be expected to cause measurable decline in muscle strength with either sustained or repetitive muscle contraction (i.e., fatigability). It recently has become possible to quantitate fatigability using the same equipment as used for fixed myometric assessment of muscle strength. Two such fatigue modalities can be measured. Static fatigue measures the rate of decline in the force generated by sustained muscle contraction during a 30-second period. Dynamic fatigue measures the decrease in peak force generated by rhythmic contractions paced at one per second for 30 seconds. These measures allow quantitation of fatigue and should allow us to determine whether complaints of fatigue are related to objective abnormalities of muscle fatigue (i.e., fatigability).
There are a number of possible theories as to the cause of fatigue in Gulf War solders. The use of acetylcholinesterase inhibitors as prophylaxis against organophosphate-based chemical attack led to the suggestion that fatigue might result from neuromuscular junction dysfunction. However, our controlled neurophysiology study showed no evidence (by either repetitive stimulation or single-fiber EMG) for neuromuscular junction dysfunction in either fatigued or nonfatigued Gulf War veterans. 6 However, alternative explanations for fatigue remain, such as those resulting from induced defects in muscle glycolytic or mitochondrial metabolism. Mitochondrial dysfunction is an attractive potential explanation for fatigue in Gulf War-related illness because the multisystem nature of the symptoms induced by mitochondrial damage could explain other common symptoms, including those related to CNS and neuromuscular function. Furthermore, those serving in the Gulf could have been exposed to a number of potential antioxidant chemicals that would have increased the likelihood of mitochondrial damage.
In this study, we examined quantitative muscle strength and fatigue using fixed myometry and also assessed muscle biopsies. We wanted to answer the question as to whether self-reported or subjective complaints of weakness or fatigue were related to objective abnormalities of weakness or fatigue. We wanted to know whether any of these symptoms might relate to particular muscle biopsy abnormalities. We also sought to determine whether complaints of fatigue could be explained by any abnormality of either muscle glycolytic or mitochondrial function. If any objective abnormalities were found, we also wanted to know whether this was specific to Gulf War service. Therefore, we used a randomly selected group of ill Gulf War veterans and compared them with healthy and ill military controls.
Methods. Subjects. We randomly selected 125 male UK military personnel (50 ill Gulf War veterans and three control groups of 25 veterans each) from our database of 8,195 symptomatic and asymptomatic service personnel from all branches of the armed services who had completed a detailed postal questionnaire, including the Medical Outcomes Study Short Form 36 (SF-36), 7 and other health outcome questionnaires, as described previously. 1 Although the SF-36 is a measure of quality of life, it has useful items of functioning. The Physical Function subscale consists of 10 items that ask the participant to rate his or her ability to carry out a range of common physical activities. We used it as a proxy marker for physical health. In the absence of any accepted case definition for Gulf War-related illness, we defined symptomatic servicemen as those who had an SF-36 physical function subscore of Ͻ72.2. This value of 72.2 represented the first decile of those service personnel who were in active service but not in an active theater of conflict and was the same as used to define disability in our previous studies. 8 Moreover, to ensure that neuromuscular symptoms were represented, we also had an additional requirement that they score more than four of the self-reported symptoms of neuromuscular dysfunction, which included fatigue, joint stiffness, muscle weakness, myalgia at rest or after exercise, sensory symptoms (e.g., paresthesia or numbness of fingers or toes), and autonomic symptoms, such as disturbances of bladder, bowel, or sexual functions. These symptomatic subjects were derived from those who had served in the Gulf War (Gulf-ill group) and, as ill control subjects, those who had served in the Bosnia peacekeeping operation from 1992 to 1997 (Bosnia-ill group), and those serving in the forces at the time but not in either conflict (Era-ill group). The well control subjects were asymptomatic persons who had served in the Gulf War with an SF-36 physical function subscore of Ͼ72.2 and who scored less than two of the self-reported symptoms of neuromuscular dysfunction (Gulf-well group). 6 Clinical assessment. As previously described, all participants were examined during a 2-day period by investigators who were not aware of their group status or clinical symptoms. 6 The assessment included a more detailed survey of the participants' neuromuscular symptoms, including the presence or absence of fatigue and its temporal relationship to exercise and the distribution and severity of their weakness, using a standard questionnaire completed by the subjects. Subjects' responses to this questionnaire were categorized as indicating global, upper limb, lower limb, proximal, or distal patterns of weakness. Subjects also completed the Chalder Fatigue Score, and results were expressed as a total score and also as physical and mental fatigue subscores. Maximum voluntary isometric contraction (MVIC) was determined using a fixed myometry (QMA System, The Computer Source, Athens, GA) by one of three clinical evaluators using methods that have demonstrated high test-retest reliability in facioscapulohumeral dystrophy. 9 Eight muscle groups were assessed bilaterally: shoulder abduction, elbow extension and flexion, hip flexion, ankle dorsiflexion, handgrip, knee flexion, and knee extension in that order to minimize positional changes and to reduce fatigue on muscle groups. The force measurements for each muscle group were transformed and standardized against the Gulf-well group allowing for age and height. This allowed expression of individual muscle MVIC scores as a Z score representing the number of SDs by which the strength of a particular muscle differed from that of the Gulf-well control subjects. These Z scores were analyzed individually but were also combined to give composite regional MVIC scores as follows: global MVIC (all 16 muscle groups), upper limb MVIC (bilateral shoulder abduction, elbow flexion and extension, and handgrip), lower limb MVIC (bilateral hip flexion, knee flexion and extension, and ankle dorsiflexion), proximal MVIC (bilateral shoulder abduction and hip flexion), and distal MVIC (bilateral handgrip and ankle dorsiflexion).
Handgrip fatigue measures were performed using a Jaymar handgrip dynamometer (Los Angeles, CA), whereas fatigue measures of other muscle groups used a fixed myometry system using a force transducer (Super Mini Load Cell, Interface Inc, Scottsdale, AZ) with limb positions as described. 9 Both were linked to QMA software (The Computer Source). Static fatigue was assessed during a single, 30-second sustained maximal contraction of the dominant ankle dorsiflexor, knee extensor, and handgrip. The static fatigue index for these muscle groups was calculated as:
where AUC ϭ area under the curve between 5 and 30 seconds and F max 0-5 ϭ maximum force exerted between 0 to 5 seconds. Dynamic fatigue was assessed in the nondominant handgrip and ankle dorsiflexion during a series of rhythmic 1-Hz maximal contractions, paced by a metronome, during a 30-second period. The dynamic fatigue index was calculated as:
where F max 25-30 ϭ maximum force exerted between 25 to 30 seconds and F max 0-5 ϭ maximum force exerted between 0 to 5 seconds.
Glycolytic function and myoadenylate deaminase activity were assessed using the ischemic forearm test (IFT). 10 Subjects performed isometric handgrip contractions using a Vigorimeter (Elmed Incorporated, Addison, IL) at 80% of their maximum strength at a rate of 0.5 Hz while a blood pressure cuff was inflated around the upper arm at 20 mm Hg more than their systolic blood pressure. This test lasted until they were unable to reach 80% of their maximum grip despite encouragement. Venous blood samples were taken pre-exercise and at 3, 5, and 7 minutes postexercise, stored on ice, and immediately spun down at the conclusion of the test for assay of lactate and ammonia. Mitochondrial function was assessed by the subanaerobic threshold exercise test (SATET). Subjects exercised on an electronically braked bicycle (Tuntori, Nottingham, UK) for 15 minutes at 60 rpm at 90% of their predicted anaerobic threshold, as calculated from their weight. 11 Continuous cardiac monitoring was performed throughout, and subjects were asked to rate perceived exertion using a Borg scale at 1-minute intervals. 12 Venous blood samples were taken pre-exercise, immediately postexercise, and 30 minutes after completion of exercise. Samples for lactate and ammonia were stored on ice and immediately spun down at the conclusion of the test. Samples for pyruvate were collected into perchloric acid (0.5 mL 8% perchloric acid ϩ 1 mL blood), mixed thoroughly, and centrifuged at 1,500g for 10 minutes to deproteinize the sample. Pyruvate was measured using a direct enzymatic method (Sigma Diagnostics, Poole, UK) on the Cobas Mira analyzer (Roche Diagnostics, Lewes, Sussex, UK). Plasma ammonia was measured using a direct enzymatic method (Trace ammonia method, Alpha Labs, Eastleigh, Hants, UK) on the Cobas Mira analyzer (Roche Diagnostics). Plasma lactate was measured using the YSI 2300 Stat glucose/lactate analyzer (Clandon-YSI Ltd., Farnborough, Hants, UK). The IFT and SATET were performed on consecutive mornings with the subjects at rest and fasted for at least 12 hours before testing.
Muscle biopsies were performed with local anesthetic using a muscle biopsy needle (Shuco International, London, UK) sampling from left vastus lateralis. Samples were frozen and processed for histology and histocytochemistry using the following stains: H-E, Gomori trichrome, succinate dehydrogenase, ATPase (at pH 9.6, 4.4, and 4.6), nicotine adenine dinucleotide tetrazolium reductase (NADH-TR), cytochrome oxidase, periodic acid-Schiff, and Sudan black. Quantitative morphometry was performed using the ATPase-stained sections at pH 9.4; the lesser diameter of 100 randomly chosen fibers was measured with a graticule, and each was assigned as either a type 1 or type 2 fiber. Using these data, atrophy and hypertrophy factors were calculated for each muscle biopsy. 13 The Institutional Review Board approved the study, and participants consented to the study with a separate additional consent for the muscle biopsy.
Statistical analysis. Statistical analysis was performed using Stata (version 7.0, StataCorp, College Station, TX). The distributions of the Z scores, for individual muscles and for regional muscle groups, and the distributions of the static and dynamic fatigue indices of each of the muscle groups were examined across the four cohorts (Gulf-well, Gulf-ill, Era-ill, and Bosnia-ill). When the normality and equal variances criteria were met, one-way analysis of variance (ANOVA) was carried out to assess mean differences between the four groups. Otherwise, nonparametric Kruskal-Wallis tests were used. Once a significant group effect was found, Bonferroni post hoc comparisons were performed to assess which of the groups were different. We carried out 2 tests to assess the association between cohort and complaints of weakness or fatigue. Chi-square tests were also used to examine the association between weakness and normality of muscle biopsy, whereas correlation analysis was carried out, and the Pearson correlation coefficient was reported, to assess the association between fatigue indices and Chalder global and physical fatigue subscores. Analysis of covariance was used to assess the main effect of weakness on average muscle strength (i.e., the difference between those who had weakness and those who did not, regardless of the group status, allowing for whether the individual was still in military service). The interaction between weakness and group also was examined to assess whether differences between those with weakness and those without depended on the group status. ANOVA was used to examine the differences in IFT and SATET results between groups and the relationship between these results and complaints of fatigue and Chalder Fatigue Scores.
Results.
Of the 142 randomly selected service and exservice personnel agreeing to attend, 110 consented to take part in this study, and quantitative myometry was performed in 109, with 26 in the Gulf-well group, 49 in the Gulf-ill group, 12 in the Bosnia-ill group, and 22 in the Era-ill group. Forty-eight (44%) servicemen 17 Gulf-well, 7 Era-ill, and 6 Bosnia-ill) were still serving in the armed forces; the rest had left the services.
Table E-1 gives the demographics of the 109 subjects, and table E-2 summarizes the numbers of subjects reporting weakness and the distribution of that weakness (see tables E-1 and E-2 on the Neurology Web site at www. neurology.org). Our recruitment strategy successfully obtained ill groups with more complaints of weakness than reported in the well control group ( 2 ϭ 24.5; df ϭ 3; p Ͻ 0.001). There was no difference in composite global MVIC scores between Gulf-ill, Bosnia-ill, Era-ill, and Gulf-well groups (F[3,97] ϭ 1.01; p ϭ 0.39; figure 1). The same was true for individual muscle MVIC scores with the exception of nondominant handgrip, which showed a difference between the Gulf-ill and Bosnia-ill groups (mean difference, Ϫ1.3; 95% CI, Ϫ2.4, Ϫ0.2; p ϭ 0.04) with the Gulf-ill group having the lowest score. To assess whether reduced MVIC scores were associated with reported patterns of weakness, we looked at differences in regional MVIC between those who had weakness and those who did not, regardless of their cohort status. We did this for five composite regional MVIC scores (as described previously) and also for four specific muscle groups bilaterally (shoulder abduction, hip flexion, ankle dorsiflexion, and handgrip) relating these to the appropriate reported distributions of weakness (see table E-3 on the Neurology Web site). Because there were significant differences in MVIC between those still in the military and those discharged, we considered this variable a potential confounder. Allowing for military status, we found associations between MVIC score and reported weakness in three of nine patterns of weakness, namely, global weakness (mean difference, Ϫ1.51; 95% CI, Ϫ2.69, Ϫ0.34; p ϭ 0.012), proximal weakness (mean difference, Ϫ0.32; 95% CI, Ϫ0.64, Ϫ0.007; p ϭ 0.04), and shoulder abduction (mean difference, Ϫ0.35; 95% CI, Ϫ0.64, Ϫ0.06; p ϭ 0.02). For each of these three significant associations, there was no interaction between the weakness and cohort This implies that the aforementioned differences in muscle strength were the same across the four cohorts (i.e., the association between reduced muscle strength and a particular distribution of weakness is not group specific). We did not find any significant evidence for association between regional MVIC score and the remaining six distributions of weakness as shown in table E-3 (see table E-3 on the Neurology Web site).
All three ill groups had a significantly higher Chalder Fatigue Score, whether total score or physical or mental subscores, than the well group regardless of deployment status (see table E-4 on the Neurology Web site). No association was found between cohort status and static or dynamic fatigue measures for each individual muscle (see table E-5 on the Neurology Web site). Table E-6 shows that there were no significant associations between the static fatigue score for any individual muscle and the Chalder Fatigue Score, with the exception of a small significant association between static fatigue for handgrip and the Chalder Fatigue Score total score and physical fatigue subscore (see table E-6 on the Neurology Web site). There was a similar lack of association between dynamic fatigue measures and Chalder Fatigue Score (see table E-6 on the Neurology Web site).
All subjects showed the expected increase in lactate and ammonia concentrations during the IFT, with no difference between the groups (lactate: F ϭ 0.66, df ϭ 3, p ϭ 0.58; ammonia: F ϭ 0.25, df ϭ 12, p ϭ 0.99).
All subjects showed similar baseline lactate and pyruvate concentrations during the SATET, but there were differences in lactate concentrations between groups at 15 and 30 minutes (figure 2). Lactate concentration at 15 minutes was higher for Gulf-ill (mean difference, 1.08; 95% CI, 0.70 to 1.46; p Ͻ 0.001) and Era-ill groups (mean difference, 0.78; 95% CI, 0.08 to 1.49; p ϭ 0.03) than that of Gulf-well group, whereas those in the Bosnia-ill group tended to have higher lactate concentrations than those in Gulf-well group (mean difference, 0.40; 95% CI, Ϫ0.07, 0.87; p ϭ 0.09). Postexercise lactate concentration at 30 minutes was higher for the Gulf-ill group than for the Gulf-well group (mean difference, 0.23; 95% CI, 0.07 to 0.38; p ϭ 0.004), but the Era-ill group (mean difference, 0.15; 95% CI, Ϫ0.10, 0.41; p ϭ 0.23) and the Bosnia-ill group (mean difference, 0.02; 95% CI, Ϫ0.24, 0.28; p ϭ 0.86) did not differ significantly from the Gulf-well group. Pyruvate concentrations showed no time by group interaction (F ϭ 1.11; df ϭ 6; p ϭ 0.36), suggesting that there was no difference between the groups in terms of baseline, peak, or recovery pyruvate concentrations.
Mean peak Borg scores for each cohort are given in table E-7 (see table E-7 on the Neurology Web site). Peak Borg scores registered during the bicycle exercise test were higher for the Gulf-ill group compared with the Gulf-well cohort (mean difference, 1.0; 95% CI, 0.50 to 1.51; p ϭ 0.01), suggesting that Gulf-ill subjects found this exercise more of an effort. The peak Borg score was only weakly associated with the Chalder Fatigue Score (Spearman rho, 0.27; p ϭ 0.004), and this was mainly because of the association with the physical fatigue subscore (Spearman rho, 0.34; p ϭ 0.0003). There was a significant, but moderate, association between peak Borg score and lactate concentration for 15 and 30 minutes (Spearman rho, 0.31; p ϭ 0.001). Peak Borg scores did not generally relate to either static or dynamic fatigue myometry scores because only a weak negative association was found with static fatigue for ankle dorsiflexion (Spearman rho, ϭ Ϫ0.20; p ϭ 0.06) and dynamic fatigue for handgrip (Spearman rho, Ϫ0.20; p ϭ 0.05).
Thirty-seven subjects consented to a muscle biopsy with no differences in the willingness to consent between the four groups ( 2 ϭ 2.13; df ϭ 3; p ϭ 0.54). Three biopsies were technically inadequate (but were classed as abnormal for the purposes of statistical analysis); 18 were normal; and 16 showed a variety of abnormalities (see table E-8 on the Neurology Web site). There was no association between those muscle biopsies showing any kind of abnormality with any reported weakness ( 2 ϭ 0.01; df ϭ 1; p ϭ 0.92), and none of the abnormalities were associated with any particular cohort. Suggestions of mitochondrial abnormality were observed in two biopsies; one biopsy from a Era-ill subject showed three cytochrome oxidase negative fibers, whereas another biopsy from a Gulf-ill subject showed an increase in trichrome staining not amounting to "ragged red change." Neither of these subjects had weakness, and their MVIC scores were not reduced.
There was no association between fiber type ratio and cohort (p ϭ 0.89), nor was there any association between fiber diameters and cohort (p ϭ 0.28 for type 1 and p ϭ 0.16 for type 2). Atrophy factors for type 1 and type 2 fibers were not related to cohort (p ϭ 0.90 for type 1 and p ϭ 0.35 for type 2), and similarly hypertrophy factors for type 1 and type 2 fibers were not related to cohort (p ϭ 0.62 for type 1 and p ϭ 0.85 for type 2). Irrespective of cohort, atrophy factors were not related to illness, either for type 1 fibers (median atrophy factor for the ill group, 37.1; range, 0 to 290.9; median for the well group, 62.5; range, 0 to 151.5; p ϭ 0.72) or for type 2 fibers (median atrophy factor for the ill group, 47.6; range, 0 to 425.5; median for the well group, 106.4; range, 0 to 307.7; p ϭ 0.35). Finally, there was no association between type 1 or 2 fiber hypertrophy factors and quantitative strength scores.
Discussion. We sought to identify possible neuromuscular causes for ill health in Gulf War veterans.
There is no accepted case definition for Gulf War ill health; therefore, we pragmatically developed a definition that selected veterans who had disability and prominent neuromuscular symptoms, reasoning that if neuromuscular causes exist for Gulf War-related illness, this group would be most likely to have neuromuscular abnormalities. The random selection of servicemen with poor physical functioning and neuromuscular symptoms from a large database of Gulf War veterans together with closely matched symptomatic and asymptomatic control subjects give us the advantage of being able to determine whether symptoms relate to objective abnormalities and whether any abnormal objective measures are specific to Gulf War service. Our case definition successfully produced ill cohorts with significantly higher levels of self-reported complaints of weakness and lower Chalder Fatigue Scores compared with the well control group.
Our original hypothesis was that any selfperceived weakness might be within the normal range clinically and hence not be detected as weakness in traditional manual muscle testing, but that such weakness might be detectable by quantitative myometry, especially with reference to matched military control subjects. We did find that those men still in service were stronger than those discharged from military service, thus supporting our use of military control subjects. The study revealed a number of significant associations between reported weakness and reduced strength as measured by quantitative myometry. However, the question is whether these statistically significant associations are clinically significant. Regardless of this judgment, what is clearly demonstrated is that any such associations, whether statistically or clinically significant, do not relate specifically to Gulf War service. Thus, we are discussing whether there is a general "postwar syndrome" and not a specific Gulf War effect. This would be consistent with the finding that a postwar syndrome has been a feature of several previous military conflicts. 14 None of the groups had significantly different individual muscle or composite MVIC scores with the exception of nondominant handgrip being 1.3 SDs less in Gulf-ill group as compared with the Bosnia-ill group. This difference is less than the traditionally accepted clinically significant difference of Ͼ2.0 SDs and is not explained by the presence of either median or ulnar neuropathy, which was only clinically evident in three Gulf-ill subjects (two with median and one with ulnar nerve compression). We increased the sensitivity of the study in picking up reduced MVIC scores in those with reported weakness by looking at regional and specific muscle MVIC scores comparable with the distribution of reported weakness. We found significant differences in such MVIC scores for four distributions of weakness. For three of these patterns of weakness, the difference was Ͻ1 SD (Ϫ0.32, Ϫ0.35, and Ϫ0.87). Two subjects, one Gulf-ill and one Era-ill, had global weakness and global MVIC scores that were a mean of Ϫ1.51 (Ϫ0.34 and Ϫ2.69) SDs less than that obtained by subjects with no reported weakness. One needs to be cautious in ascribing true significance to the mean difference between a group containing just 2 individuals and a larger group of 98 individuals (those who did not have any weakness). Therefore, we believe that none of our data reflect clinically significant objective weakness to correlate with self-perceived weakness.
More recently it has been suggested that ALS, for which the cardinal symptom is weakness, may be more likely in Gulf War service personnel. [15] [16] [17] Although in ALS it is objective rather than subjective weakness that makes the diagnosis, it is recognized that weakness caused by ALS may only be detectable using quantitative myometry before it is detectable on manual muscle testing. Given the rarity of ALS, it is not surprising that we found no cases of ALS in any of our subjects, but complaints of weakness are much more common than ALS, and it is reassuring to realize that, in all probability, the majority of such complaints are not associated with abnormal quantitative myometry that would suggest preclinical ALS.
Static fatigue and dynamic fatigue muscle measures were unrelated to the ill status of subjects. Neither fatigue measure correlated with Chalder Fatigue Scores, with the exception of a small association between static fatigue for handgrip and the total Chalder Fatigue Score. The total Chalder Fatigue Score includes elements of mental and physical fatigue, and it would seem logical that measures of motor fatigue might better correlate with the Chalder Fatigue physical subscore. However, with the exception of a small association with static fatigue for handgrip, the Chalder Fatigue physical subscores did not correlate with the motor fatigue measurements. Thus, it seems that individuals have a measurable perception of fatigue, whether mental or physical, that does not relate to any objective measure of muscle fatigue.
Our knowledge of the relationship between different fatigue states and the quantitative motor fatigue measures is limited because the latter have only recently become available. A study looking at quantitative strength and fatigue measurements in patients with multiple sclerosis showed that quantifiable fatigue was seen in these subjects and that it sometimes occurred in strong muscles. However, this study did not relate quantitative fatigue to any selfrated scale of fatigue. 18 Some models of fatigue suggest that muscle fatigue may have a central and a peripheral element. The peripheral element may re-late to defects in neuromuscular transmission or muscle function, such as biochemical deficiency, whereas the central element is less well understood but may result in a reduced upper motor neuron drive to the lower motor neuron units. It has been suggested that central fatigue may be distinguished from peripheral fatigue by the ability to obtain additional muscle strength over and above apparent maximal voluntary isometric contraction using central stimulation (e.g., by magnetic coils). Such a model clearly does not apply in our subjects, in whom quantitative muscle strength (maximal voluntary isometric contraction) and quantitative fatigue measures are not reduced.
This study does not address the issue of mental as opposed to physical fatigue, which may account for the low mental fatigue subscores of the Chalder Fatigue Scale. It is possible that mental fatigue, although not contributing to any centrally derived muscle fatigue, nevertheless induces a subjective feeling of physical fatigue. It has been suggested that the perception of fatigue in the absence of true weakness or fatigability may be explicable based on a primary disturbance of the sense of effort, and if so, one may predict that peak Borg scores during exercise should correlate with Chalder Fatigue Scores. 19 Our study showed only a weak association between peak Borg scores in exercise and Chalder Fatigue Scores, mainly with the physical fatigue subscore.
With respect to the potential causes for peripheral muscle fatigue, we have already shown that there is no evidence for any neuromuscular transmission defect in "ill" subjects regardless of cohort. 6 This study showed no evidence for any defect in muscle glycolytic metabolism or myoadenylate deaminase activity as judged by the normal lactate and ammonia concentration responses during the IFTs. However, the SATET showed a significantly higher peak and recovery lactate concentration in Gulf-ill subjects as compared with Gulf-well and Bosnia-ill subjects. This suggests that mitochondrial respiratory chain function is relatively impaired in Gulf-ill subjects. In mitochondrial disease, acquired or genetic defects of the mitochondrial oxidative phosphorylation system can lead to multisystem disorders, including muscle weakness and fatigability. In many, but not all, cases, the defect of oxidative phosphorylation triggers an unsuccessful attempt at compensation by way of mitochondrial proliferation, and this may be seen in muscle biopsy samples as ragged-red fibers. The elevated lactate concentrations seen in the Gulfill group are not of the magnitude seen in traditional mitochondrial muscle disease associated with ragged-red fibers in muscle biopsies. None of our subjects had ragged-red fibers on their muscle biopsies, but subtle mitochondrial abnormalities were seen in two cases. It may be that the abnormal SATET results reflect a subtle mitochondrial abnormality that is not sufficient to trigger the full picture of a mitochondrial disease in muscle but that is sufficient to cause some of the symptoms described in the Gulf-ill subjects. Having said that, the fact is that we have not been able to find objective evidence for weakness or fatigue that would be expected for a mitochondrial abnormality. This study does not tell us whether any such mitochondrial abnormalities are more or less pronounced in the CNS, nor whether these would account for any CNS-derived symptoms.
A second explanation for the impaired SATET results may be that these reflect the "unfitness" or "detrained state" of the subjects caused by their symptoms. Untrained or unfit subjects do have less efficient mitochondrial respiratory chain function as compared with fit or active subjects. 20 The mitochondrial inefficiency may be a reflection, rather than the cause, of the ill state of the subjects. In support of the suggestion that Gulf-ill subjects were less fit is the fact that they were significantly heavier than the control groups, perhaps as a result of a more sedentary lifestyle induced by their symptoms or having left the armed forces. Gulf-ill subjects also had a significantly higher perception of the effort required to complete the bicycle exercise test, with a general, but not cohort specific, association between peak Borg scores and the extent of the increase in lactate concentrations. This again may reflect the unfit state.
One would not expect physiologically induced mitochondrial inefficiency, relating to lack of fitness, to result in objective physical weakness or fatigue, nor would it trigger ragged-red fibers in the muscle biopsy. If this mitochondrial inefficiency were merely a reflection of the "ill" state and the unfitness induced by this, then one might suppose that the same effect would be seen with all three ill groups. Only the Gulf-ill group showed a significant difference in the SATET compared with the Gulf-well group. However, although there was no significant difference between the Gulf-ill and Era-ill groups, looking at the graphs (see figure 1 ) one can see that the ill cohorts all showed a trend toward higher peak and recovery lactate concentrations compared with the Gulf-well cohort. Thus, it may be that the significant result seen with the Gulf-ill group reflects the degree to which they were unfit and that this in turn may relate to the number of symptoms that they have. Bearing in mind that our ill cohorts did not have objective impairment of muscle function, it is possible that perceived muscle impairment or other nonmuscle symptoms (e.g., CNS or non-neurologic symptoms) were contributing to this unfitness.
If mitochondrial abnormality was the cause rather than the effect of symptoms, how might this have come about? Gulf War service personnel were exposed to a number of factors that might damage mitochondrial DNA (mtDNA) given its increased susceptibility to mutational damage when exposed to antioxidants. Such damage would be expected to be random in its distribution within the mtDNA genome, resulting in multiple deletions and mutations. The mtDNA mutations become fixed in postmitotic tissue, such as muscle and brain, where there is less opportunity for mtDNA mutations to be selected out during successive cell divisions. Therefore, one might predict that the main effects of such mitochondrial damage would be seen in muscle and in the CNS, which does seems to equate with many of the symptoms described in Gulf-well veterans. With age one tends to accumulate mtDNA mutations; therefore, mitochondrial function declines as one gets older. Thus, one would predict that the effects of any preexisting war-related mitochondrial damage would worsen with time and result in increasing symptoms.
We found muscle biopsy abnormalities in 16 of 34 samples, most of which on their own would be considered minor and of doubtful, or uncertain, significance in the normal clinical setting. But regardless of any subjective view as to the clinical significance of these biopsy abnormalities, the design of our study allows us to say that these abnormalities are not related to complaints of weakness, lower MVIC scores, or military service, whether in the Gulf War or not. It has been suggested that mitochondrial abnormalities may have resulted from toxic exposure during Gulf War service, but histochemical abnormalities suggestive of mitochondrial abnormality were only found in two subjects, both from ill groups, neither of whom had weakness, and with only one having served in the Gulf War. This Gulf War subject had a mild increase in peripheral trichrome staining, which is a subjective finding of arguable significance in terms of mitochondrial function. However, the three cytochrome oxidase negative fibers seen in the Era-ill subject would be regarded as definitely abnormal in a 46-year-old person. Quantitative morphometric analysis did not show fiber type ratio or fiber diameters to be associated with cohort. Muscle fiber diameters tend to reflect muscle activity, with atrophy associated with disuse and hypertrophy associated with increased activity, especially for type 2 fibers. However, neither atrophy nor hypertrophy factors were associated with illness, nor were they associated with perceived or actual weakness.
Thus, quantitative assessments and the muscle biopsies did not show abnormalities that related to the self-perception of weakness or fatigue, and we have not found a Gulf War-specific effect. This finding is supported by the lack of any specific neurophysiologic abnormalities in our subjects. 6 It also confirms the findings of the only similar, but uncontrolled, study of neuromuscular symptoms in Gulf War veterans. 5 This study adds to the information given by the neurophysiology study in that quantitative muscle strength scores, were they abnormal, could have reflected upper motor neuron weakness that might not have been detected by neurophysiology. The lack of any specific Gulf War effect is in keeping with the fact that although the prevalence of symptoms in Gulf War veterans is higher as compared with veterans of the Bosnia campaign and serving, but not deployed, troops, the pattern of symptoms is the same for all three groups. 1 The fail-ure to correlate symptoms of weakness or fatigue with objective assessments of abnormalities of weakness or muscle biopsy abnormalities should not be taken as evidence that such self-reported symptoms are not genuine nor worthy of concern. However, it does suggest that their origin does not lie in the neuromuscular system. We have found that Gulf-ill subjects found exercise more effortful and that it generated more lactic acid than with control subjects, but we are unable to say conclusively whether this was the result of lack of fitness or the subtle, perhaps environmentally induced, mitochondrial damage. Ultimately the discussion as to whether apparent mitochondrial inefficiency is cause or effect could be resolved by direct analysis of mtDNA using real-time PCR techniques to see whether the amount of mtDNA mutations in postmitotic tissue (e.g., muscle) is greater in ill service personnel vs matched control subjects.
